D-0569-2022 Class III Terminated
FDA drug recall D-0569-2022 was initiated by BayCare Integrated Service Center, LLC /Dba BayCare Central Pharmacy on Feb 14, 2022 and is designated Class III. Reason for recall: Subpotent drug The recall status is terminated (terminated Dec 8, 2022). Affected quantity: 1157 bags.
Recall details
- Product Type
- Drugs
- Report Date
- Mar 2, 2022
- Initiation Date
- Feb 14, 2022
- Termination Date
- Dec 8, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1157 bags
Product description
Norepinephrine bitartrate 16 mg in 250 mL NaCl 0.9%, packaged in IV bags, Rx only, BayCare Central Pharmacy 7802 E. Telecom Parkway Temple Terrace, FL 33637 (813) 901-6392
Reason for recall
Subpotent drug
Distribution pattern
Florida
Code information
Lot #: Nore1620220111, Nore1620220113, Nore1620220118, Nore1620220125, Nore1620220127, Nore1620220202, Exp 3/31/22
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0569-2022
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026